Cargando…
MCM10: An effective treatment target and a prognostic biomarker in patients with uterine corpus endometrial carcinoma
Molecular profiling has been applied for uterine corpus endometrial carcinoma (UCEC) management for many years. The aim of this study was to explore the role of MCM10 in UCEC and construct its overall survival (OS) prediction models. Data from TCGA, GEO, cbioPotal and COSMIC databases and the method...
Autores principales: | Chen, Junyu, Wu, Shan, Wang, Junwei, Han, Chunying, Zhao, Lijing, He, Kang, Jia, Yan, Cui, Manhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10273062/ https://www.ncbi.nlm.nih.gov/pubmed/37246638 http://dx.doi.org/10.1111/jcmm.17772 |
Ejemplares similares
-
KNL1 is a prognostic and diagnostic biomarker related to immune infiltration in patients with uterine corpus endometrial carcinoma
por: He, Kang, et al.
Publicado: (2023) -
Comprehensive Analysis of the Expression and Prognosis for MCM4 in Uterine Corpus Endometrial Carcinoma
por: Pei, Li-Peng, et al.
Publicado: (2022) -
PPP1R14B is a diagnostic prognostic marker in patients with uterine corpus endometrial carcinoma
por: He, Kang, et al.
Publicado: (2023) -
RPP40 is a prognostic biomarker and correlated with tumor microenvironment in uterine corpus endometrial carcinoma
por: Tang, Jianming, et al.
Publicado: (2022) -
Mammaglobin B may be a prognostic biomarker of uterine corpus endometrial cancer
por: Li, Jie, et al.
Publicado: (2020)